Arcturus Therapeutics Investor Relations Material

Arcturus Therapeutics Holdings, Inc. is an RNA medicines company. The Company is engaged in the development of vaccines for infectious and liver and respiratory rare diseases in the United States. The company develops immunotherapies based on its delivery technology, which can be engineered to express messenger ribonucleic acid (RNA) in vivo with high efficiency. It is developing small-molecule drugs and vaccines for infectious, liver and respiratory diseases using its RNAi-based technology platforms.